Far-field potentials (FFPs), nerve signals that can be measured on the skin, show promise as diagnostic and prognostic ...

An auction to help Creston Nelson, a state Senate staffer, is open through today to help her family pay uncovered health care ...

Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on ...

Matteo Materazzi's battle against a rare form of ALS has prompted his wife to launch a fundraiser to fund personalized ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

A recent study has revealed a critical gap in the use of accessibility features among people living with Amyotrophic Lateral ...

Apple's new thought control protocol has now been shown in use by Synchron, a medical company that has made a prototype for using iPads solely by thinking.

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

Trethera Corporation initiates a clinical trial for TRE-515, exploring its potential in oncology and autoimmune diseases ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...